MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications

D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros, S. Jesús, M. Aguilar, LL. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, MA. Avila, MJ. Catalán, L. López Díaz, JM. García Moreno, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, JC. Martínez Castrillo, P. Sánchez Alonso, MG. Alonso Losada, N. López Ariztegui, P. Martínez Martín, SG. Coppadis (A Coruña, Spain)

Meeting: 2019 International Congress

Abstract Number: 1619

Keywords: Dyskinesias, Motor control, Non-motor Scales

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Objective: To analyze how motor complications are related to non-motor symptoms (NMS) burden in a population of early Parkinson´s disease (PD) patients.

Background: It is known that NMS burden is greater and many NMS are more prevalent in advanced PD patients with motor complications (MC). However, the relationship between NMS and MC in early PD patients has not been properly studied.

Method: PD patients from the COPPADIS cohort [1] were included in this cross-sectional study. NMS burden was defined according to the NMSS (Non-Motor Symptoms Scale) total score. UPDRS (Unified Parkinson´s Disease Rating Scale) part-IV was used to establish motor complication types and their severity. Patients with ≤ 5 years of symptoms from onset were included as early PD patients.

Results: A total of 396 PD patients (61.9 ± 9 years old, 58.1% males) with a mean disease duration of 2.7 ± 1.5 years were included. Of them, the 18.1% (75/396) and 5.8% (23/396) presented motor fluctuations and dyskinesia, respectively. NMSS total score was higher in patients with motor fluctuations (59.3 ± 44.6 vs 38.3 ± 33.4; p<0.0001) and with dyskinesia (65 ± 35.8 vs 40.9 ± 36.3; p=0.002). Scores on UPDRS-IV, UPDRS-IV-B (dyskinesias), and UPDRS-IV-A (clinical fluctuations) related to NMS burden (p<0.0001). In a multiple linear regression model and after adjustment to age, sex, disease duration, H&Y, UPDRS-III, BDI-II and levodopa equivalent daily dose, UPDRS-IV was significantly related to a higher NMSS total score (β=0.24; 95%CI 3.3-7.43; p<0.0001), as it was in a logistic regression model on dichotomous NMSS total score (≤40, mild or moderate, vs. >40, severe or very severe): OR=1.28; 95%CI 1.05-1.56; p=0.015.

Conclusion: A relationship between MC and NMS exists even in early PD patients. MC are frequent and are related to NMS burden already during the first years after diagnosis.

References: 1. Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, et al.; COPPADIS Study Group. COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global–clinical evaluations, serum biomarkers, genetic studies and neuroimaging–prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression. BMC Neurol 2016;16:26.

To cite this abstract in AMA style:

D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros, S. Jesús, M. Aguilar, LL. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, MA. Avila, MJ. Catalán, L. López Díaz, JM. García Moreno, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, JC. Martínez Castrillo, P. Sánchez Alonso, MG. Alonso Losada, N. López Ariztegui, P. Martínez Martín, SG. Coppadis. Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/non-motor-symptoms-burden-is-greater-in-early-parkinsons-disease-patients-with-motor-complications/. Accessed July 1, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/non-motor-symptoms-burden-is-greater-in-early-parkinsons-disease-patients-with-motor-complications/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley